Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Gastroenterology ; 140(7): 2009-18, 2018.e1-4, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21354149

ABSTRACT

BACKGROUND & AIMS: Fas belongs to the family of tumor necrosis factor receptors which induce apoptosis. Many cancer cells express Fas but do not undergo Fas-mediated apoptosis. Nitric oxide reverses this resistance by increasing levels of Fas at the plasma membrane. We studied the mechanisms by which NO affects Fas function. METHODS: Colon and mammary cancer cell lines were incubated with the NO donor glyceryl trinitrate or lipid A; S-nitrosylation of Fas was monitored using the biotin switch assay. Fas constructs that contained mutations at cysteine residues that prevent S-nitrosylation were used to investigate the involvement of S-nitrosylation in Fas-mediated cell death. Apoptosis was monitored according to morphologic criteria. RESULTS: NO induced S-nitrosylation of cysteine residues 199 and 304 in the cytoplasmic part of Fas. In cancer cells that overexpressed wild-type Fas, S-nitrosylation induced Fas recruitment to lipid rafts and sensitized the cells to Fas ligand. In cells that expressed a mutant form of Fas in which cysteine 304 was replaced by valine residue, NO-mediated translocation of Fas to lipid rafts was affected and the death-inducing signal complex and synergistic effect of glyceryl trinitrate-Fas ligand were inhibited significantly. These effects were not observed in cells that expressed Fas with a mutation at cysteine 199. CONCLUSIONS: We identified post-translational modifications (S-nitrosylation of cysteine residues 199 and 304) in the cytoplasmic domain of Fas. S-nitrosylation at cysteine 304 promotes redistribution of Fas to lipid rafts, formation of the death-inducing signal complex, and induction of cell death.


Subject(s)
Apoptosis , Colonic Neoplasms/metabolism , Fas Ligand Protein/metabolism , Mammary Neoplasms, Experimental/metabolism , Nitric Oxide/metabolism , Protein Processing, Post-Translational , fas Receptor/metabolism , Animals , Apoptosis/drug effects , Biotinylation , Cell Line, Tumor , Colonic Neoplasms/genetics , Colonic Neoplasms/pathology , Cysteine , Female , Humans , Lipid A/pharmacology , Mammary Neoplasms, Experimental/genetics , Mammary Neoplasms, Experimental/pathology , Membrane Microdomains/metabolism , Mice , Mutation , Nitric Oxide Donors/pharmacology , Nitroglycerin/pharmacology , Protein Processing, Post-Translational/drug effects , Protein Transport , Signal Transduction , Time Factors , Transfection , fas Receptor/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...